BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 29392885)

  • 21. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential.
    Zheng Y; Watanabe N; Nagamura-Inoue T; Igura K; Nagayama H; Tojo A; Tanosaki R; Takaue Y; Okamoto S; Takahashi TA
    Exp Hematol; 2003 Dec; 31(12):1237-46. PubMed ID: 14662330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenografts.
    Schaniel C; Papa L; Meseck ML; Kintali M; Djedaini M; Zangui M; Iancu-Rubin C; Hoffman R
    Cytotherapy; 2021 Sep; 23(9):841-851. PubMed ID: 34023194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short-term culture in the presence of an aryl hydrocarbon receptor antagonist.
    Gu A; Torres-Coronado M; Tran CA; Vu H; Epps EW; Chung J; Gonzalez N; Blanchard S; DiGiusto DL
    Hum Gene Ther Methods; 2014 Aug; 25(4):221-31. PubMed ID: 25003230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation.
    Wang JF; Wang LJ; Wu YF; Xiang Y; Xie CG; Jia BB; Harrington J; McNiece IK
    Haematologica; 2004 Jul; 89(7):837-44. PubMed ID: 15257936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells.
    Kadekar D; Kale V; Limaye L
    Stem Cell Res Ther; 2015 Oct; 6():201. PubMed ID: 26481144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelium-targeted human Delta-like 1 enhances the regeneration and homing of human cord blood stem and progenitor cells.
    Tian DM; Liang YM; Zhang YQ
    J Transl Med; 2016 Jan; 14():5. PubMed ID: 26740017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
    Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
    Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.
    da Silva CL; Gonçalves R; dos Santos F; Andrade PZ; Almeida-Porada G; Cabral JM
    J Tissue Eng Regen Med; 2010 Feb; 4(2):149-58. PubMed ID: 19937912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells.
    Arulmozhivarman G; Kräter M; Wobus M; Friedrichs J; Bejestani EP; Müller K; Lambert K; Alexopoulou D; Dahl A; Stöter M; Bickle M; Shayegi N; Hampe J; Stölzel F; Brand M; von Bonin M; Bornhäuser M
    Sci Rep; 2017 Sep; 7(1):12084. PubMed ID: 28935977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biological characteristics of mesenchymal stem cells in human umbilical cord blood and their supporting capacities in ex vivo expansion of CD34+ hematopoietic stem cells].
    Wang LJ; Zhang YP; Wang JF; Wu YF; Xiang Y; Xie CG; Jia BB; Harrington J; McNiece IK
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):65-8. PubMed ID: 15921619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic reprogramming induces the expansion of cord blood stem cells.
    Chaurasia P; Gajzer DC; Schaniel C; D'Souza S; Hoffman R
    J Clin Invest; 2014 Jun; 124(6):2378-95. PubMed ID: 24762436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial CD34+ cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion.
    Andrade PZ; da Silva CL; dos Santos F; Almeida-Porada G; Cabral JM
    J Cell Biochem; 2011 Jul; 112(7):1822-31. PubMed ID: 21400571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic.
    Faivre L; Parietti V; Siñeriz F; Chantepie S; Gilbert-Sirieix M; Albanese P; Larghero J; Vanneaux V
    Stem Cell Res Ther; 2016 Jan; 7():3. PubMed ID: 26742480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of HPCs from cord blood in a novel 3D matrix.
    Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
    Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells.
    Delalat B; Pourfathollah AA; Soleimani M; Mozdarani H; Ghaemi SR; Movassaghpour AA; Kaviani S
    Hematology; 2009 Jun; 14(3):125-32. PubMed ID: 19490756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC.
    Forraz N; Pettengell R; McGuckin CP
    Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echinochrome A Promotes Ex Vivo Expansion of Peripheral Blood-Derived CD34
    Park GB; Kim MJ; Vasileva EA; Mishchenko NP; Fedoreyev SA; Stonik VA; Han J; Lee HS; Kim D; Jeong JY
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31505769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.